Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (10)
P 2 (4)
P 3 (3)

Trial Status

Completed8
Recruiting7
Not Yet Recruiting5
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT07329907Phase 2Completed

Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic

NCT07429071Not ApplicableRecruiting

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

NCT07601074Phase 2Not Yet RecruitingPrimary

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

NCT07678047Not ApplicableEnrolling By Invitation

Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia

NCT07513389Phase 2Recruiting

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

NCT07637734Phase 3Not Yet Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

NCT06825689Not ApplicableRecruitingPrimary

Unidos Contra el VPH

NCT07457918Phase 3Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

NCT07545525Not Yet Recruiting

HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy

NCT07214584Recruiting

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

NCT07358910Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

NCT07246590Phase 3Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

NCT07307131Phase 2Completed

Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts

NCT07207655Not ApplicableNot Yet RecruitingPrimary

Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV)

NCT07110909Not ApplicableCompletedPrimary

Impact of HPV Education on Knowledge, Awareness, and Concern

NCT07036211Not Yet RecruitingPrimary

Transmission of Oncogenic HPV Infection Among Families

NCT06920589Not ApplicableCompletedPrimary

Human Papilloma Virus Awareness Intervention

NCT06909370Not ApplicableCompletedPrimary

Peer Education on HPV: Impact on Health Sciences Students' Knowledge, Awareness, and Concern

NCT03987490Not ApplicableCompletedPrimary

Usability of HPV Vaccine Reminders

NCT00709891Not ApplicableCompletedPrimary

Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease

Scroll to load more

Research Network

Activity Timeline